Stock Research: OPKO Health

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

OPKO Health

NasdaqGS:OPK US68375N1037
27
  • Value
    65
  • Growth
    11
  • Safety
    Safety
    47
  • Combined
    20
  • Sentiment
    35
  • 360° View
    360° View
    27
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. It operates in pharmaceutical and diagnostics industries, with key pharmaceutical products like Somatrogon (NGENLA) and Rayaldee, and clinical laboratory operations through BioReference. Its pharmaceutical operations are in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, and the United States. In the last fiscal year, the company had a market cap of $1071 millions, profits of $219 millions, revenue of $713 millions, and 2997 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 27 (better than 27% compared with alternatives), overall professional sentiment and financial characteristics for the stock OPKO Health are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four metrics below average for OPKO Health. The only rank that is above average is the consolidated Safety Rank at 65, which means that the company has a financing structure that is safer than those of 65% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the Value, Growth and Sentiment Ranks are all below average. The consolidated Value Rank has a less desirable rank of 47, which means that the share price of OPKO Health is on the high side compared with typical size in indicators such as revenues, profits, and invested capital. The consolidated Growth Rank also has a low rank of 11, which implies that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. Finally, the consolidated Sentiment Rank is also low at a rank of 35, which means that professional investors are more pessimistic about the stock than for 65% of alternative investment opportunities. While Safety is strong, it’s not the most critical indicator, so we suggest proceeding with caution if you are considering this stock. ...read more

more
Index
NASDAQ
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 41 44 18
Growth
11 57 67 1
Safety
Safety
65 86 49 61
Sentiment
35 49 42 13
360° View
360° View
27 77 38 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
97 95 95 95
Opinions Change
50 50 50 50
Pro Holdings
n/a 51 44 3
Market Pulse
4 10 7 4
Sentiment
35 49 42 13
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
47 41 44 18
Growth
11 57 67 1
Safety Safety
65 86 49 61
Combined
20 82 10 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 1 1 1
Price vs. Earnings (P/E)
25 23 31 25
Price vs. Book (P/B)
74 84 85 79
Dividend Yield
1 1 1 1
Value
47 41 44 18
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 10 6 1
Profit Growth
4 76 80 38
Capital Growth
46 28 75 4
Stock Returns
35 93 85 63
Growth
11 57 67 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
67 85 82 80
Refinancing
90 94 43 45
Liquidity
9 9 15 40
Safety Safety
65 86 49 61

Similar Stocks

Discover high‑ranked alternatives to OPKO Health and broaden your portfolio horizons.

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Alphabet

NasdaqGS:GOOG.L
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.